BRAIN Biotech AG and Formo Bio GmbH are launching a strategic collaboration to further advance the production of animal-free milk proteins. Biotech companies BRAIN Biotech AG and Formo Bio GmbH want to drive forward the animal-free production of milk proteins as part of their strategic cooperation. Formo will scale up their bioidentical milk protein production with a genome editing technology, leveraging BRAIN Biotech's expertise and its proprietary BEC platform. The alliance aims to optimize the microorganisms to further expand novel and sustainable protein production for commercial use through precision fermentation. Berlin based start-up Formo is introducing an entirely novel product category alongside both animal-derived products and plant-based alternatives by producing identical milk proteins with specialized microorganisms. As the first European company, Formo strives to revolutionize the $700 billion dairy market while cutting down on gigatons of CO_2 emissions. Formo builds on the increasing demand for sustainable food among consumers: Recently, the company conducted a consumer survey confirming that 79% of consumers are willing to try animal-free cheese products.
展开▼